Reversal of Remimazolam-Mediated Inhibition of Jurkat T Cell Activation by TGFBI Depletion
Immune Discovery · 2025
DOI: 10.70322/immune.2025.10009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immune Discovery, 2025. Verfasst von Hao Wang und 11 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
GABAA receptors are well-recognized targets for intravenous anesthetics and have been identified in T lymphocytes. Remimazolam, a GABAA receptor-binding agent, enhances the inhibitory effects of γ-aminobutyric acid (GABA) and provides a rapid onset and offset of sedation, making it suitable for procedural sedation and anesthesia. However, the impact of remimazolam on T cell function remains poorly understood. In this study, we used mass spectrometry analysis to confirm that Jurkat T cells produce and secrete GABA de novo. Consequently, treatment with remimazolam inhibited Jurkat T cell activation, even in the absence of exogenous GABA. Transcriptomic profiling of remimazolam-treated Jurkat T cells exhibited a significant upregulation of TGFBI expression. Furthermore, CRISPR/Cas9-mediated knockout of TGFBI reversed the inhibitory effects of remimazolam on Jurkat T cell activation. These findings highlight the profound influence of anesthetics on T cell activation and could be crucial for optimizing their clinical application.
Zitieren
APA
Wang, H., Gao, G., Ma, H., Qi, Y., Zhang, B., Liu, T., Liu, Y., Li, T., Zhang, L., Wang, H., Liang, Y., & Zhou, B. (2025). Reversal of Remimazolam-Mediated Inhibition of Jurkat T Cell Activation by TGFBI Depletion. Immune Discovery. https://doi.org/10.70322/immune.2025.10009
Vancouver
Wang H, Gao G, Ma H, Qi Y, Zhang B, Liu T, et al. Reversal of Remimazolam-Mediated Inhibition of Jurkat T Cell Activation by TGFBI Depletion. Immune Discovery. 2025. doi:10.70322/immune.2025.10009
BibTeX
@article{Wang2025,
author = {Wang, Hao and Gao, Ge and Ma, Haoyuan and Qi, Yingcheng and Zhang, Bowen and Liu, Tingting and Liu, Yang and Li, Tianhan and Zhang, Lichen and Wang, Hui and Liang, Yinming and Zhou, Binhui},
title = {Reversal of Remimazolam-Mediated Inhibition of Jurkat T Cell Activation by TGFBI Depletion},
journal = {Immune Discovery},
year = {2025},
doi = {10.70322/immune.2025.10009}
}
EUVIMED